{"frequencyBands":{"HP:0040280":[100,100],"HP:0040281":[80,99],"HP:0040282":[30,79],"HP:0040283":[5,29],"HP:0040284":[1,4],"HP:0040285":[0,0]},"page":{"anchorSlug":"aldosterone-producing-adenoma-with-seizures-and-neurological-abnormalities","columns":[{"gene":"","key":"population-f877a40c97a3de290b22","label":"Primary aldosteronism, seizures, and neurologic abnormalities","mondoId":"MONDO:0014200","onsetQualifier":null,"originColumnKey":"MONDO:0014200/OMIM:615474","originalViews":[{"key":"MONDO:0014200/OMIM:615474","label":"Primary aldosteronism, seizures, and neurologic abnormalities","scopeLabel":"OMIM:615474","sourceScope":"This column retains the native source entry. It is not a pooled estimate for the umbrella condition."}],"recordKeys":["0047fb8a3d33a01648103f017475115b1fd6fa655899d060657493b1c08be7d1","05abdcead67a55e33945a12fb3eb0c0be90089269c0c00c0f8e53afc9f304ad1","16750d87cdd1535462585b9f96257035171208aaabb888946f2c1f6f2113b73d","1e8817b9992282bcc694bdf9d3f92db7bcc7bf5b04def75c679a821f75b63f65","1eb12177a77f9667b9e75c45762a61f66c7aec4c7dc694c41a8432d7abaf4b4a","2104b49de301c8acaf52f9bdd5e0d969c6b372c4912cb5d09d69acac33ef232b","30000662157c21eceadf428131c77faa183af91d2717be20c082a18fadc6e542","30b11f23310f3e9f32892b86766b58333d281859228c7e5378f17119a07c3acb","3e7926773400340124e471fe06b31c1b0887f1cd777740a451d02a99b8cf1ed4","408e76f024c96b81c9a68ffec67743771bfeb9e185b41631cd16f46798384140","56fc0608ac2d3be825973585a642791220557ed8a7a500c1be26f7c498217d72","8b6d7d05ea56865310894d8061c813463ade9585e4ae81e8b9a59e9af6945675","8c4af93d98376d612372dc6cf394e7549328754daa5a8792f49bee61a3d96b1a","8d4a710ee88070c18557612919e58238f7bf163434ace4f9c98cd4f99e4d8257","9b957966ebf2410d6f1dbeff1dc20ed3db1e528eb63864b53bf26c340384122f","b6c9e784c220b908a18fa7adb8fbe98a5465ed02fee4b8caa0340abbd7efd529","c3764c493d61f68e746f9300e8cf7e110a9f2b4a5c63213cccbb2fe3fe47d726","c426e0cf05c815aedcffa95b91bbcd975cc795aeca1a476cdfa81f4a90b537f6","d8a284724b2078765489d568fa78a59390305001d75c8a33846193a965d64347","dfa9766343b7f6b613fa49b2d9642ef37494886c573b8ea397d322b79b6a86b0","e71c33fa85191862021787869e8a3991e25500d76d4072d90fa6505dfae1a828"],"recordQualifiers":{},"scopeLabel":"OMIM:615474","sourceIds":["OMIM:615474"],"sourceScope":"This column retains the native source entry. It is not a pooled estimate for the umbrella condition."},{"gene":"","key":"population-39e15905069b37d90189","label":"Primary hyperaldosteronism-seizures-neurological abnormalities syndrome","mondoId":"MONDO:0014200","onsetQualifier":null,"originColumnKey":"MONDO:0014200/ORPHA:369929","originalViews":[{"key":"MONDO:0014200/ORPHA:369929","label":"Primary hyperaldosteronism-seizures-neurological abnormalities syndrome","scopeLabel":"ORPHA:369929","sourceScope":"This column retains the native source entry. It is not a pooled estimate for the umbrella condition."}],"recordKeys":["03d85f0285ba3facb6b58c8b07ce91922bd08d45dbe8dd68b30875a43b9e0e52","04ce27f26d85606a411c2d788aa8473e5be682e40559da87d913c4e8086056d2","06b4736ee08345112582a583ec6735bd8d75556759342fcf9bc95359514dfcc7","1bf59f630c7bf03cc26a3e137d6ccb8fce76af208fb1a9889eb98463febc4e99","1da730fc88533002eb712f486b533c1af46009e1e8d3a2d7270bfa14a6d375fd","1e9d78e620a5a28b661c57e69c16af9ce54a3fb7c2eb69794c7cf346a03829a5","1f62546724d3474aa6331ed1249d97ac4e36ff6bf57b69454581f2dea8f64cbf","27159aaebe26b7aeb6aa8af287c2df8412400312a5b3a35cf373c70e7d7b1a6c","2bf765e4cf6290119fc36989d98858acc890d2fb303897f0bed3a12158b1bbdc","2e30b862b1cb564aea7893611ca5a49329e85b932f7bd42a8953265d3b8e6b71","2f272df9609aad191ccb2ac955b695fefb831290326e96ac3afb6cc461da4bf9","322f55d034908061930f26cf63feefeda57870c3a3221f6a228d5385329acbc0","355ae2dd670494fc110e0cd6e84f75e0886deefc5e5c5482fbf8efb80cb3dbab","41e2748041eea15a4998998754d7f24ec43e866847e1a235ca9d6ff3aed07841","4916298cc38472102241a17f2d573080c6e8abd783086b605397183bf45d9485","4d349f72f39260fb85dc0a34ea82e0b9ec7fe0c8b006893e6542fc351893ccd8","54db46f6d54e1f8d68f5bb174d48799fa6cd40470229bad306b93984d80f7a93","60909779fd7c93508be6937fac340248d92f07b17c6a01050c9b23babe5273fe","6b4d2cbe3cf5a3584e65bbf08aa754d13e0062cc265f4100d3c9a505760cc4fe","6b621b6e008fc040d56abce2b78f4c2fdefd373f0b38550e2531f71295daf8cf","7d390af4275d3fb7fafefedcf4e118f44e3971357e6516af82c649a880c0156d","a3862d2257dbadd816b33db5dee53ccf26674f968ec1a71d1a2abdc93e3d9410","b85ab9ddf552b50f72756891ac531e0f60bad01ffe0c978e489f526fe307d392","bddf7d9e6a170988bff60f0043df5b9b4844f9e3e383e5dbd9901dd831e2f68a","d76c103e4892a58d325889524c366617a3fb925afa9e9d520b27365ae99ca02a","d7d68853eab43edcc1592897125646634e19d6b9504ca84958ac8714ff2d727d","da1d17a13ab16d3c05ac045ff2af5b80812256090d0d2ac3e00324e0991b721f","f32554d710133848c12b53cce8409d0cf8e8502a28503e9abd25687a1f787f22","f586e9af3da5e4b2789668c42dc5b6e4d096e06e665ac680f30ca5b5b6d11603","ff009689da096707f6bb62e12a7f90dd10187806c36b266e2eb09af6cd2a7b84"],"recordQualifiers":{},"scopeLabel":"ORPHA:369929","sourceIds":["ORPHA:369929"],"sourceScope":"This column retains the native source entry. It is not a pooled estimate for the umbrella condition."}],"comparison":{"collapseColumnsLabel":"Show default populations","defaultColumnKeys":["population-f877a40c97a3de290b22","population-39e15905069b37d90189"],"expandColumnsLabel":"Show all source populations","intro":"Features recorded for this MONDO node. Related-node evidence is available through separately scoped comparisons.","primaryFeatureIds":["HP:0040084","HP:0008221","HP:0002305","HP:0002069","HP:0200128","HP:0011410","HP:0100021"],"scopeNoteHtml":"<p>Each column retains its native condition identifier, assessed population and annotation references. Counts are not pooled.</p>"},"coverage":{"countRecords":21,"emptyColumnKeys":[],"hpoRelease":"2026-06-23","narrativeSourceChanges":[],"records":51,"sourceGroups":{"orphanet":30,"published":21}},"features":[{"hpoId":"HP:0040084","label":"Abnormal circulating renin concentration","primary":true},{"hpoId":"HP:0008221","label":"Adrenal hyperplasia","primary":true},{"hpoId":"HP:0002305","label":"Athetosis","primary":true},{"hpoId":"HP:0002069","label":"Bilateral tonic-clonic seizure","primary":true},{"hpoId":"HP:0200128","label":"Biventricular hypertrophy","primary":true},{"hpoId":"HP:0011410","label":"Caesarean section","primary":true},{"hpoId":"HP:0100021","label":"Cerebral palsy","primary":true},{"hpoId":"HP:0100704","label":"Cerebral visual impairment","primary":false},{"hpoId":"HP:0003351","label":"Decreased circulating renin concentration","primary":false},{"hpoId":"HP:0011739","label":"Dexamethasone-suppressible primary hyperaldosteronism","primary":false},{"hpoId":"HP:0100285","label":"EMG: impaired neuromuscular transmission","primary":false},{"hpoId":"HP:0000421","label":"Epistaxis","primary":false},{"hpoId":"HP:0002384","label":"Focal impaired awareness seizure","primary":false},{"hpoId":"HP:0011166","label":"Focal myoclonic seizure","primary":false},{"hpoId":"HP:0001263","label":"Global developmental delay","primary":false},{"hpoId":"HP:0002315","label":"Headache","primary":false},{"hpoId":"HP:0000822","label":"Hypertension","primary":false},{"hpoId":"HP:0002900","label":"Hypokalemia","primary":false},{"hpoId":"HP:0000859","label":"Increased circulating aldosterone concentration","primary":false},{"hpoId":"HP:0001249","label":"Intellectual disability","primary":false},{"hpoId":"HP:0002170","label":"Intracranial hemorrhage","primary":false},{"hpoId":"HP:0000787","label":"Kidney stone","primary":false},{"hpoId":"HP:0001712","label":"Left ventricular hypertrophy","primary":false},{"hpoId":"HP:0200114","label":"Metabolic alkalosis","primary":false},{"hpoId":"HP:0032794","label":"Myoclonic seizure","primary":false},{"hpoId":"HP:0002018","label":"Nausea","primary":false},{"hpoId":"HP:0001655","label":"Patent foramen ovale","primary":false},{"hpoId":"HP:0001959","label":"Polydipsia","primary":false},{"hpoId":"HP:0011736","label":"Primary hyperaldosteronism","primary":false},{"hpoId":"HP:0002092","label":"Pulmonary arterial hypertension","primary":false},{"hpoId":"HP:0011706","label":"Second degree atrioventricular block","primary":false},{"hpoId":"HP:0001250","label":"Seizure","primary":false},{"hpoId":"HP:0010864","label":"Severe intellectual disability","primary":false},{"hpoId":"HP:0001258","label":"Spastic paraplegia","primary":false},{"hpoId":"HP:0002510","label":"Spastic tetraplegia","primary":false},{"hpoId":"HP:0001257","label":"Spasticity","primary":false},{"hpoId":"HP:0000360","label":"Tinnitus","primary":false},{"hpoId":"HP:0001714","label":"Ventricular hypertrophy","primary":false},{"hpoId":"HP:0001629","label":"Ventricular septal defect","primary":false}],"ledeHtml":"A rare, genetic, neurologic disease characterized by primary hyperaldosteronism presenting with early-onset, severe hypertension, hypokalemia and neurological manifestations (including seizures, severe hypotonia, spasticity, cerebral palsy and profound developmental delay/intellectual disability).","mondoId":"MONDO:0014200","node":{"canonicalSlug":"aldosterone-producing-adenoma-with-seizures-and-neurological-abnormalities","comparisons":[{"documentSha256":"af8816dbbfaa4a637f0aba7a052096caf62e546aab923d7802ee2ff2cbf12ee3","key":"legacy-familial-hyperaldosteronism","kind":"legacy","label":"familial hyperaldosteronism","memberIds":["MONDO:0007080","MONDO:0013359","MONDO:0014200","MONDO:0014875","MONDO:0016525"],"mondoId":"MONDO:0016525","url":"https://kcjyutqgtpgteszueluf.supabase.co/storage/v1/object/public/community-guides/learn-data/familial-hyperaldosteronism.af8816dbbfaa4a637f0aba7a052096caf62e546aab923d7802ee2ff2cbf12ee3.json"},{"documentSha256":"43a80b93c19f2aebe625ef5ea18c3cd0b59ed004ce48da183812054416e9bb9a","key":"expanded-familial-hyperaldosteronism","kind":"expanded","label":"familial hyperaldosteronism","memberIds":["MONDO:0007080","MONDO:0011576","MONDO:0013359","MONDO:0014200","MONDO:0014875","MONDO:0016525"],"mondoId":"MONDO:0016525","url":"https://kcjyutqgtpgteszueluf.supabase.co/storage/v1/object/public/community-guides/learn-data/node-comparison-43a80b93c19f2aebe625.43a80b93c19f2aebe625ef5ea18c3cd0b59ed004ce48da183812054416e9bb9a.json"}],"contexts":[],"lifecycle":"active","narrative":{"causes":[],"contentForm":"summary","independentCorroborationEstablished":false,"matchMethod":"automatic-identity-and-attribution","name":"Aldosterone-producing adenoma with seizures and neurological abnormalities","originalSourceId":"ORPHA:369929","paragraphs":["A rare, genetic, neurologic disease characterized by primary hyperaldosteronism presenting with early-onset, severe hypertension, hypokalemia and neurological manifestations (including seizures, severe hypotonia, spasticity, cerebral palsy and profound developmental delay/intellectual disability)."],"rawAttribution":"ORPHA:369929","reviewed":null,"scope":"exact","source":"GARD","sourceRelease":"2026-10-25T03:42:28Z","upstream":"ORPHA:369929","url":"https://rarediseases.info.nih.gov/diseases/17591"},"ownColumnKeys":["population-f877a40c97a3de290b22","population-39e15905069b37d90189"],"publication":"published","relationships":[{"kind":"parent","label":"familial hyperaldosteronism","mondoId":"MONDO:0016525","slug":"familial-hyperaldosteronism"}],"schemaVersion":1,"searchIndex":"/node-search/manifest.json","sourceHolds":{},"summaryHolds":[],"translation":"pending"},"records":[{"frequencyKind":"count","key":"0047fb8a3d33a01648103f017475115b1fd6fa655899d060657493b1c08be7d1","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:615474","disease_name":"Primary aldosteronism, seizures, and neurologic abnormalities","evidence":"PCS","frequency_raw":"1/2","hpo_id":"HP:0200114","is_excluded":false,"label":"Metabolic alkalosis","onset_id":null,"reference":"PMID:23913001","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"range","key":"03d85f0285ba3facb6b58c8b07ce91922bd08d45dbe8dd68b30875a43b9e0e52","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:369929","disease_name":"Primary hyperaldosteronism-seizures-neurological abnormalities syndrome","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0002315","is_excluded":false,"label":"Headache","onset_id":null,"reference":"ORPHA:369929","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"04ce27f26d85606a411c2d788aa8473e5be682e40559da87d913c4e8086056d2","raw":{"aspect":"P","body_system":"respiratory","disease_id":"ORPHA:369929","disease_name":"Primary hyperaldosteronism-seizures-neurological abnormalities syndrome","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0002092","is_excluded":false,"label":"Pulmonary arterial hypertension","onset_id":null,"reference":"ORPHA:369929","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"count","key":"05abdcead67a55e33945a12fb3eb0c0be90089269c0c00c0f8e53afc9f304ad1","raw":{"aspect":"P","body_system":"respiratory","disease_id":"OMIM:615474","disease_name":"Primary aldosteronism, seizures, and neurologic abnormalities","evidence":"PCS","frequency_raw":"1/2","hpo_id":"HP:0002092","is_excluded":false,"label":"Pulmonary arterial hypertension","onset_id":null,"reference":"PMID:23913001","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"range","key":"06b4736ee08345112582a583ec6735bd8d75556759342fcf9bc95359514dfcc7","raw":{"aspect":"P","body_system":"prenatal","disease_id":"ORPHA:369929","disease_name":"Primary hyperaldosteronism-seizures-neurological abnormalities syndrome","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0011410","is_excluded":false,"label":"Caesarean section","onset_id":null,"reference":"ORPHA:369929","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"count","key":"16750d87cdd1535462585b9f96257035171208aaabb888946f2c1f6f2113b73d","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:615474","disease_name":"Primary aldosteronism, seizures, and neurologic abnormalities","evidence":"PCS","frequency_raw":"1/2","hpo_id":"HP:0002305","is_excluded":false,"label":"Athetosis","onset_id":null,"reference":"PMID:23913001","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"range","key":"1bf59f630c7bf03cc26a3e137d6ccb8fce76af208fb1a9889eb98463febc4e99","raw":{"aspect":"P","body_system":"blood","disease_id":"ORPHA:369929","disease_name":"Primary hyperaldosteronism-seizures-neurological abnormalities syndrome","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0002170","is_excluded":false,"label":"Intracranial hemorrhage","onset_id":null,"reference":"ORPHA:369929","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"1da730fc88533002eb712f486b533c1af46009e1e8d3a2d7270bfa14a6d375fd","raw":{"aspect":"P","body_system":"endocrine","disease_id":"ORPHA:369929","disease_name":"Primary hyperaldosteronism-seizures-neurological abnormalities syndrome","evidence":"TAS","frequency_raw":"HP:0040280","hpo_id":"HP:0040084","is_excluded":false,"label":"Abnormal circulating renin concentration","onset_id":null,"reference":"ORPHA:369929","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"count","key":"1e8817b9992282bcc694bdf9d3f92db7bcc7bf5b04def75c679a821f75b63f65","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:615474","disease_name":"Primary aldosteronism, seizures, and neurologic abnormalities","evidence":"PCS","frequency_raw":"1/2","hpo_id":"HP:0001257","is_excluded":false,"label":"Spasticity","onset_id":null,"reference":"PMID:23913001","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"range","key":"1e9d78e620a5a28b661c57e69c16af9ce54a3fb7c2eb69794c7cf346a03829a5","raw":{"aspect":"P","body_system":"cardiovascular","disease_id":"ORPHA:369929","disease_name":"Primary hyperaldosteronism-seizures-neurological abnormalities syndrome","evidence":"TAS","frequency_raw":"HP:0040280","hpo_id":"HP:0000822","is_excluded":false,"label":"Hypertension","onset_id":null,"reference":"ORPHA:369929","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"count","key":"1eb12177a77f9667b9e75c45762a61f66c7aec4c7dc694c41a8432d7abaf4b4a","raw":{"aspect":"P","body_system":"cardiovascular","disease_id":"OMIM:615474","disease_name":"Primary aldosteronism, seizures, and neurologic abnormalities","evidence":"PCS","frequency_raw":"2/2","hpo_id":"HP:0000822","is_excluded":false,"label":"Hypertension","onset_id":"HP:0003623","reference":"PMID:23913001","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"reported","key":"1f62546724d3474aa6331ed1249d97ac4e36ff6bf57b69454581f2dea8f64cbf","raw":{"aspect":"P","body_system":"endocrine","disease_id":"ORPHA:369929","disease_name":"Primary hyperaldosteronism-seizures-neurological abnormalities syndrome","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0011739","is_excluded":true,"label":"Dexamethasone-suppressible primary hyperaldosteronism","onset_id":null,"reference":"ORPHA:369929","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"count","key":"2104b49de301c8acaf52f9bdd5e0d969c6b372c4912cb5d09d69acac33ef232b","raw":{"aspect":"P","body_system":"eye","disease_id":"OMIM:615474","disease_name":"Primary aldosteronism, seizures, and neurologic abnormalities","evidence":"PCS","frequency_raw":"1/2","hpo_id":"HP:0100704","is_excluded":false,"label":"Cerebral visual impairment","onset_id":null,"reference":"PMID:23913001","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"range","key":"27159aaebe26b7aeb6aa8af287c2df8412400312a5b3a35cf373c70e7d7b1a6c","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:369929","disease_name":"Primary hyperaldosteronism-seizures-neurological abnormalities syndrome","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0001263","is_excluded":false,"label":"Global developmental delay","onset_id":null,"reference":"ORPHA:369929","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"2bf765e4cf6290119fc36989d98858acc890d2fb303897f0bed3a12158b1bbdc","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:369929","disease_name":"Primary hyperaldosteronism-seizures-neurological abnormalities syndrome","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0002384","is_excluded":false,"label":"Focal impaired awareness seizure","onset_id":null,"reference":"ORPHA:369929","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"2e30b862b1cb564aea7893611ca5a49329e85b932f7bd42a8953265d3b8e6b71","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"ORPHA:369929","disease_name":"Primary hyperaldosteronism-seizures-neurological abnormalities syndrome","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0100285","is_excluded":false,"label":"EMG: impaired neuromuscular transmission","onset_id":null,"reference":"ORPHA:369929","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"2f272df9609aad191ccb2ac955b695fefb831290326e96ac3afb6cc461da4bf9","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:369929","disease_name":"Primary hyperaldosteronism-seizures-neurological abnormalities syndrome","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0100021","is_excluded":false,"label":"Cerebral palsy","onset_id":null,"reference":"ORPHA:369929","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"count","key":"30000662157c21eceadf428131c77faa183af91d2717be20c082a18fadc6e542","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:615474","disease_name":"Primary aldosteronism, seizures, and neurologic abnormalities","evidence":"PCS","frequency_raw":"2/2","hpo_id":"HP:0100021","is_excluded":false,"label":"Cerebral palsy","onset_id":null,"reference":"PMID:23913001","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"30b11f23310f3e9f32892b86766b58333d281859228c7e5378f17119a07c3acb","raw":{"aspect":"P","body_system":"cardiovascular","disease_id":"OMIM:615474","disease_name":"Primary aldosteronism, seizures, and neurologic abnormalities","evidence":"PCS","frequency_raw":"1/2","hpo_id":"HP:0001712","is_excluded":false,"label":"Left ventricular hypertrophy","onset_id":null,"reference":"PMID:23913001","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"range","key":"322f55d034908061930f26cf63feefeda57870c3a3221f6a228d5385329acbc0","raw":{"aspect":"P","body_system":"eye","disease_id":"ORPHA:369929","disease_name":"Primary hyperaldosteronism-seizures-neurological abnormalities syndrome","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0100704","is_excluded":false,"label":"Cerebral visual impairment","onset_id":null,"reference":"ORPHA:369929","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"355ae2dd670494fc110e0cd6e84f75e0886deefc5e5c5482fbf8efb80cb3dbab","raw":{"aspect":"P","body_system":"metabolic","disease_id":"ORPHA:369929","disease_name":"Primary hyperaldosteronism-seizures-neurological abnormalities syndrome","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0002900","is_excluded":false,"label":"Hypokalemia","onset_id":null,"reference":"ORPHA:369929","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"count","key":"3e7926773400340124e471fe06b31c1b0887f1cd777740a451d02a99b8cf1ed4","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:615474","disease_name":"Primary aldosteronism, seizures, and neurologic abnormalities","evidence":"PCS","frequency_raw":"2/2","hpo_id":"HP:0002900","is_excluded":false,"label":"Hypokalemia","onset_id":null,"reference":"PMID:23913001","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"408e76f024c96b81c9a68ffec67743771bfeb9e185b41631cd16f46798384140","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:615474","disease_name":"Primary aldosteronism, seizures, and neurologic abnormalities","evidence":"PCS","frequency_raw":"1/2","hpo_id":"HP:0001249","is_excluded":false,"label":"Intellectual disability","onset_id":null,"reference":"PMID:23913001","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"range","key":"41e2748041eea15a4998998754d7f24ec43e866847e1a235ca9d6ff3aed07841","raw":{"aspect":"P","body_system":"metabolic","disease_id":"ORPHA:369929","disease_name":"Primary hyperaldosteronism-seizures-neurological abnormalities syndrome","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0200114","is_excluded":false,"label":"Metabolic alkalosis","onset_id":null,"reference":"ORPHA:369929","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"4916298cc38472102241a17f2d573080c6e8abd783086b605397183bf45d9485","raw":{"aspect":"P","body_system":"blood","disease_id":"ORPHA:369929","disease_name":"Primary hyperaldosteronism-seizures-neurological abnormalities syndrome","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0000421","is_excluded":false,"label":"Epistaxis","onset_id":null,"reference":"ORPHA:369929","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"4d349f72f39260fb85dc0a34ea82e0b9ec7fe0c8b006893e6542fc351893ccd8","raw":{"aspect":"P","body_system":"endocrine","disease_id":"ORPHA:369929","disease_name":"Primary hyperaldosteronism-seizures-neurological abnormalities syndrome","evidence":"TAS","frequency_raw":"HP:0040280","hpo_id":"HP:0000859","is_excluded":false,"label":"Increased circulating aldosterone concentration","onset_id":null,"reference":"ORPHA:369929","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"54db46f6d54e1f8d68f5bb174d48799fa6cd40470229bad306b93984d80f7a93","raw":{"aspect":"P","body_system":"genitourinary","disease_id":"ORPHA:369929","disease_name":"Primary hyperaldosteronism-seizures-neurological abnormalities syndrome","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0000787","is_excluded":false,"label":"Kidney stone","onset_id":null,"reference":"ORPHA:369929","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"count","key":"56fc0608ac2d3be825973585a642791220557ed8a7a500c1be26f7c498217d72","raw":{"aspect":"P","body_system":"genitourinary","disease_id":"OMIM:615474","disease_name":"Primary aldosteronism, seizures, and neurologic abnormalities","evidence":"PCS","frequency_raw":"1/2","hpo_id":"HP:0000787","is_excluded":false,"label":"Kidney stone","onset_id":null,"reference":"PMID:23913001","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"range","key":"60909779fd7c93508be6937fac340248d92f07b17c6a01050c9b23babe5273fe","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:369929","disease_name":"Primary hyperaldosteronism-seizures-neurological abnormalities syndrome","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0001250","is_excluded":false,"label":"Seizure","onset_id":null,"reference":"ORPHA:369929","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"6b4d2cbe3cf5a3584e65bbf08aa754d13e0062cc265f4100d3c9a505760cc4fe","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:369929","disease_name":"Primary hyperaldosteronism-seizures-neurological abnormalities syndrome","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0010864","is_excluded":false,"label":"Severe intellectual disability","onset_id":null,"reference":"ORPHA:369929","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"6b621b6e008fc040d56abce2b78f4c2fdefd373f0b38550e2531f71295daf8cf","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:369929","disease_name":"Primary hyperaldosteronism-seizures-neurological abnormalities syndrome","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0001959","is_excluded":false,"label":"Polydipsia","onset_id":null,"reference":"ORPHA:369929","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"7d390af4275d3fb7fafefedcf4e118f44e3971357e6516af82c649a880c0156d","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:369929","disease_name":"Primary hyperaldosteronism-seizures-neurological abnormalities syndrome","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0011166","is_excluded":false,"label":"Focal myoclonic seizure","onset_id":null,"reference":"ORPHA:369929","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"count","key":"8b6d7d05ea56865310894d8061c813463ade9585e4ae81e8b9a59e9af6945675","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:615474","disease_name":"Primary aldosteronism, seizures, and neurologic abnormalities","evidence":"PCS","frequency_raw":"2/2","hpo_id":"HP:0001263","is_excluded":false,"label":"Global developmental delay","onset_id":null,"reference":"PMID:23913001","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"8c4af93d98376d612372dc6cf394e7549328754daa5a8792f49bee61a3d96b1a","raw":{"aspect":"P","body_system":"endocrine","disease_id":"OMIM:615474","disease_name":"Primary aldosteronism, seizures, and neurologic abnormalities","evidence":"PCS","frequency_raw":"1/2","hpo_id":"HP:0011736","is_excluded":false,"label":"Primary hyperaldosteronism","onset_id":null,"reference":"PMID:23913001","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"8d4a710ee88070c18557612919e58238f7bf163434ace4f9c98cd4f99e4d8257","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:615474","disease_name":"Primary aldosteronism, seizures, and neurologic abnormalities","evidence":"PCS","frequency_raw":"1/2","hpo_id":"HP:0002069","is_excluded":false,"label":"Bilateral tonic-clonic seizure","onset_id":null,"reference":"PMID:23913001","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"9b957966ebf2410d6f1dbeff1dc20ed3db1e528eb63864b53bf26c340384122f","raw":{"aspect":"P","body_system":"endocrine","disease_id":"OMIM:615474","disease_name":"Primary aldosteronism, seizures, and neurologic abnormalities","evidence":"PCS","frequency_raw":"2/2","hpo_id":"HP:0003351","is_excluded":false,"label":"Decreased circulating renin concentration","onset_id":null,"reference":"PMID:23913001","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"range","key":"a3862d2257dbadd816b33db5dee53ccf26674f968ec1a71d1a2abdc93e3d9410","raw":{"aspect":"P","body_system":"cardiovascular","disease_id":"ORPHA:369929","disease_name":"Primary hyperaldosteronism-seizures-neurological abnormalities syndrome","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0001714","is_excluded":false,"label":"Ventricular hypertrophy","onset_id":null,"reference":"ORPHA:369929","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"count","key":"b6c9e784c220b908a18fa7adb8fbe98a5465ed02fee4b8caa0340abbd7efd529","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:615474","disease_name":"Primary aldosteronism, seizures, and neurologic abnormalities","evidence":"PCS","frequency_raw":"1/2","hpo_id":"HP:0002510","is_excluded":false,"label":"Spastic tetraplegia","onset_id":null,"reference":"PMID:23913001","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"range","key":"b85ab9ddf552b50f72756891ac531e0f60bad01ffe0c978e489f526fe307d392","raw":{"aspect":"P","body_system":"cardiovascular","disease_id":"ORPHA:369929","disease_name":"Primary hyperaldosteronism-seizures-neurological abnormalities syndrome","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0001629","is_excluded":false,"label":"Ventricular septal defect","onset_id":null,"reference":"ORPHA:369929","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"bddf7d9e6a170988bff60f0043df5b9b4844f9e3e383e5dbd9901dd831e2f68a","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:369929","disease_name":"Primary hyperaldosteronism-seizures-neurological abnormalities syndrome","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0002069","is_excluded":false,"label":"Bilateral tonic-clonic seizure","onset_id":null,"reference":"ORPHA:369929","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"count","key":"c3764c493d61f68e746f9300e8cf7e110a9f2b4a5c63213cccbb2fe3fe47d726","raw":{"aspect":"P","body_system":"cardiovascular","disease_id":"OMIM:615474","disease_name":"Primary aldosteronism, seizures, and neurologic abnormalities","evidence":"PCS","frequency_raw":"1/2","hpo_id":"HP:0001629","is_excluded":false,"label":"Ventricular septal defect","onset_id":null,"reference":"PMID:23913001","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"c426e0cf05c815aedcffa95b91bbcd975cc795aeca1a476cdfa81f4a90b537f6","raw":{"aspect":"P","body_system":"cardiovascular","disease_id":"OMIM:615474","disease_name":"Primary aldosteronism, seizures, and neurologic abnormalities","evidence":"PCS","frequency_raw":"1/2","hpo_id":"HP:0001655","is_excluded":false,"label":"Patent foramen ovale","onset_id":null,"reference":"PMID:23913001","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"range","key":"d76c103e4892a58d325889524c366617a3fb925afa9e9d520b27365ae99ca02a","raw":{"aspect":"P","body_system":"digestive","disease_id":"ORPHA:369929","disease_name":"Primary hyperaldosteronism-seizures-neurological abnormalities syndrome","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0002018","is_excluded":false,"label":"Nausea","onset_id":null,"reference":"ORPHA:369929","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"d7d68853eab43edcc1592897125646634e19d6b9504ca84958ac8714ff2d727d","raw":{"aspect":"P","body_system":"ear","disease_id":"ORPHA:369929","disease_name":"Primary hyperaldosteronism-seizures-neurological abnormalities syndrome","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0000360","is_excluded":false,"label":"Tinnitus","onset_id":null,"reference":"ORPHA:369929","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"count","key":"d8a284724b2078765489d568fa78a59390305001d75c8a33846193a965d64347","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:615474","disease_name":"Primary aldosteronism, seizures, and neurologic abnormalities","evidence":"PCS","frequency_raw":"1/2","hpo_id":"HP:0032794","is_excluded":false,"label":"Myoclonic seizure","onset_id":null,"reference":"PMID:23913001","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"range","key":"da1d17a13ab16d3c05ac045ff2af5b80812256090d0d2ac3e00324e0991b721f","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:369929","disease_name":"Primary hyperaldosteronism-seizures-neurological abnormalities syndrome","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0002305","is_excluded":false,"label":"Athetosis","onset_id":null,"reference":"ORPHA:369929","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"count","key":"dfa9766343b7f6b613fa49b2d9642ef37494886c573b8ea397d322b79b6a86b0","raw":{"aspect":"P","body_system":"cardiovascular","disease_id":"OMIM:615474","disease_name":"Primary aldosteronism, seizures, and neurologic abnormalities","evidence":"PCS","frequency_raw":"1/2","hpo_id":"HP:0011706","is_excluded":false,"label":"Second degree atrioventricular block","onset_id":null,"reference":"PMID:23913001","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"e71c33fa85191862021787869e8a3991e25500d76d4072d90fa6505dfae1a828","raw":{"aspect":"P","body_system":"cardiovascular","disease_id":"OMIM:615474","disease_name":"Primary aldosteronism, seizures, and neurologic abnormalities","evidence":"PCS","frequency_raw":"1/2","hpo_id":"HP:0200128","is_excluded":false,"label":"Biventricular hypertrophy","onset_id":null,"reference":"PMID:23913001","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"range","key":"f32554d710133848c12b53cce8409d0cf8e8502a28503e9abd25687a1f787f22","raw":{"aspect":"P","body_system":"endocrine","disease_id":"ORPHA:369929","disease_name":"Primary hyperaldosteronism-seizures-neurological abnormalities syndrome","evidence":"TAS","frequency_raw":"HP:0040284","hpo_id":"HP:0008221","is_excluded":false,"label":"Adrenal hyperplasia","onset_id":null,"reference":"ORPHA:369929","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"f586e9af3da5e4b2789668c42dc5b6e4d096e06e665ac680f30ca5b5b6d11603","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:369929","disease_name":"Primary hyperaldosteronism-seizures-neurological abnormalities syndrome","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0001258","is_excluded":false,"label":"Spastic paraplegia","onset_id":null,"reference":"ORPHA:369929","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"ff009689da096707f6bb62e12a7f90dd10187806c36b266e2eb09af6cd2a7b84","raw":{"aspect":"P","body_system":"cardiovascular","disease_id":"ORPHA:369929","disease_name":"Primary hyperaldosteronism-seizures-neurological abnormalities syndrome","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0011706","is_excluded":false,"label":"Second degree atrioventricular block","onset_id":null,"reference":"ORPHA:369929","source_release":"2026-06-23"},"sourceGroups":["orphanet"]}],"referenceLabels":{},"references":{"causeHtml":"<p class=\"section-source\">Source: <a href=\"https://rarediseases.info.nih.gov/diseases/17591\" rel=\"noreferrer\">GARD</a></p><p class=\"section-source\">Source: <a href=\"https://monarchinitiative.org/MONDO:0014200\" rel=\"noreferrer\">MONDO</a></p><details class=\"deep-dive\"><summary>Narrative source and scope</summary><dl><dt>Content</dt><dd>summary</dd><dt>Scope</dt><dd>exact</dd><dt>Match method</dt><dd>automatic-identity-and-attribution</dd><dt>Upstream attribution</dt><dd>ORPHA:369929</dd></dl></details>","identityNote":"MONDO identifies this node. Native source populations, annotation references and qualified comparison views retain their original scopes.","importantHtml":""},"sections":[{"bodyHtml":"<p>A rare, genetic, neurologic disease characterized by primary hyperaldosteronism presenting with early-onset, severe hypertension, hypokalemia and neurological manifestations (including seizures, severe hypotonia, spasticity, cerebral palsy and profound developmental delay/intellectual disability).</p><p class=\"section-source\">Source: <a href=\"https://rarediseases.info.nih.gov/diseases/17591\" rel=\"noreferrer\">GARD</a></p>","key":"overview","title":"Overview"}],"sharedSources":[],"slug":"aldosterone-producing-adenoma-with-seizures-and-neurological-abnormalities","sourceDocuments":[{"name":"GARD: Aldosterone-producing adenoma with seizures and neurological abnormalities","reviewed":null,"source_release":"2026-10-25T03:42:28Z","url":"https://rarediseases.info.nih.gov/diseases/17591"},{"name":"MONDO: aldosterone-producing adenoma with seizures and neurological abnormalities","reviewed":null,"source_release":"releases/2026-10-06","url":"https://monarchinitiative.org/MONDO:0014200"}],"sourceNote":"","synonyms":["aldosterone-secreting adenoma with seizures and neurological abnormalities","APA with seizures and neurological abnormalities","complex neurodevelopmental disorder with or without aldosteronism","Conn adenoma with seizures and neurological abnormalities","PASNA","primary aldosteronism, seizures, and neurologic abnormalities"],"takeawayHtml":"","title":"aldosterone-producing adenoma with seizures and neurological abnormalities"},"schemaVersion":1}
